Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib

Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell disorder that can precede the diagnosis of multiple myeloma. MGUS is characterized by the presence of a monoclonal paraprotein without evidence of multiple myeloma or other lymphoplasmacytic malignancies. Even though MGUS is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2023-05, Vol.55 (4), p.770-774
Hauptverfasser:	Saldanha, Artur, Veiga, Maria Eduarda, Okazaki, Erica, Rothschild, Cynthia, Martinez, Gracia, Rocha, Vanderson, Orsi, Fernanda A., Villaca, Paula
Format:	Artikel
Sprache:	eng
Schlagworte:	Benign monoclonal gammopathy Bleeding Bortezomib Bortezomib - therapeutic use Cardiology Case reports Coronary artery disease Cyclophosphamide Dexamethasone Diagnosis Glucocorticoids Heart diseases Hematology Humans Immunoproliferative diseases Letter to the Editor Lymphocytes Malignancy Medicine Medicine & Public Health Monoclonal Gammopathy of Undetermined Significance - complications Monoclonal Gammopathy of Undetermined Significance - drug therapy Multiple myeloma Multiple Myeloma - complications Multiple Myeloma - drug therapy Myeloma Proteins Paraproteinemias - complications Paraproteinemias - drug therapy Remission von Willebrand Diseases - complications von Willebrand Diseases - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!